Source: Constellation Pharmaceuticals , Inc. From: globenewswire.com Clinical activity of CPI-1205 was seen in subsets of advanced metastatic castration-resistant prostate cancer (mCRPC) patients Recently initiated Phase 2 portion of ProSTAR includes randomized testing of CPI-1205 in combination with enzalutamide versus enzalutamide alone, as well as CPI-1205 in combination with abiraterone Initial update from Phase 2 portion of ProSTAR expected in …
FDA Warns About Robotic Mastectomy, Other Surgeries
By: Nick Mulcahy From: medscape.com The US Food and Drug Administration (FDA) today issued a safety communication to healthcare providers about the use of robotically assisted surgical devices for mastectomy and other cancer-related surgeries that are not already FDA approved. The agency urged caution about any such use. Robotic devices are approved for use in prostate cancer but not in most …
Racial disparities in US cancer deaths are shrinking, study finds
Posted By: CNN Wire From: wtvr.com Racial disparities in cancer deaths between black and white patients in the United States are receding — but more progress is needed to completely close the gap for some cancer types and age groups, according to a new study. Among men, the overall cancer death rate was 47% higher for blacks than for whites …
Veru Initiates Clinical Trial for Proprietary, Novel, First-in-Class Drug for Advanced Prostate Cancer
Source: Veru, Inc. From: globenewswire.com Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that it has initiated and enrolled the first patient in a clinical trial of its proprietary, next generation prostate cancer drug, VERU-111. The open-label Phase 1b/2 clinical trial for VERU-111, a novel oral drug, will be evaluated in men with metastatic refractory prostate …
Living With Cancer: Some Men With Prostate Cancer Opt Out of Surgery
From: newsroom.cedars-sinai.org Dale White was diagnosed with prostate cancer six years ago. His doctor told him that surviving prostate cancer depended on one treatment option: surgery. ”I was shocked. I thought that was too radical,” said White, 69. ”So I searched for other options and ended up at Cedars-Sinai, where Dr. Posadas told me I was a good candidate for active …
Hormone Therapy Can Make Prostate Cancer Worse, Study Finds
Scientists at Cedars-Sinai have discovered how prostate cancer can sometimes withstand and outwit a standard hormone therapy, causing the cancer to spread. Their findings also point to a simple blood test that may help doctors predict when this type of hormone therapy resistance will occur. Prostate cancer is the second-leading cause of cancer death in men, behind lung cancer, killing …
What Is Active Surveillance for Breast Cancer?
By Elaine K. Howley From: health.usnews.com Cancer cells don’t all grow and spread at the same speed. Some, as with prostate cancer, can be slow-growing, so oncologists have taken the approach at times that it’s safe to do so-called watchful waiting, or active surveillance, to see if the cancer starts to cause problems before they undertake invasive treatments. Active surveillance …
New Blood Test May Detect Multiple Types of Cancer at Earlier Stages
From: healthline.com Screening methods for certain types of cancer, particularly breast cancer and prostate cancer, can lead to early diagnosis. However, there’s no catchall test to screen for every one of the more than 100 types of cancer that exist. Researchers at GRAIL, a Silicon Valley healthcare company, are working on a DNA test based off a simple blood draw that can …
This ‘metastasis-blocking’ compound may stop the spread of cancer
By: Catharine Paddock PhD From: medicalnewstoday.com Using a new approach, scientists have located a compound that stops the spread of breast, pancreatic, and prostate cancers in mice. The compound — which they call metarrestin — destroys a unique structure inside the nucleus of cancer cells that can spread and form new tumors. A paper on the work — in which researchers from the National Institutes …
Blood test could detect people’s breast cancer risk at birth and save millions of lives, research claims
By: Sun Reporter From: thesun.co.uk Doctor Anna Rose’s revolutionary research could mean that previously overlooked information could now be used to actually identify cancers at an earlier stage. A SIMPLE blood test costing a few pounds could detect the risk of cancer at birth. Researcher Dr Anna Rose, 31, of the John Radcliffe Hospital in Oxford, found a test on …